HIV-1 gp120 V3 Loop for Structure-Based Drug Design

Publisher： Bentham Science Publishers

E-ISSN： 1875-5550|6|5|413-422

ISSN： 1389-2037

Source： Current Protein and Peptide Science, Vol.6, Iss.5, 2005-10, pp. : 413-422

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Structure-based Design of a Constrained Peptide Mimic of the HIV-1 V3 Loop Neutralization Site

By Ghiara J.B.   Ferguson D.C.   Satterthwait A.C.   Dyson H.J.   Wilson I.A.  

Journal of Molecular Biology, Vol. 266, Iss. 1, 1997-02 ,pp. : 31-39

Academic Press

Access to resources Recommend Favorite

Loss of N-linked glycans in the V3-loop region of gp120 is correlated to an enhanced infectivity of HIV-1

By Dittmar M.  

Glycobiology, Vol. 11, Iss. 1, 2001-01 ,pp. : 11-19

Oxford University Press

Access to resources Recommend Favorite

Crystal engineering of HIV-1 reverse transcriptase for structure-based drug design

By Bauman Joseph D.  

Nucleic Acids Research, Vol. 36, Iss. 15, 2008-09 ,pp. : 5083-5092

Oxford University Press

Access to resources Recommend Favorite

Dys-Regulation of Effector CD4+ T Cell Function by the V3 Domain of the HIV-1 gp120 during Antigen Presentation

By Zafiropoulos A.   Baritaki S.   Vlata Z.   Spandidos D.A.   Krambovitis E.  

Biochemical and Biophysical Research Communications, Vol. 284, Iss. 4, 2001-06 ,pp. : 875-879

Elsevier

Access to resources Recommend Favorite

Expression, Purification, and Isotope Labeling of a gp120 V3 Peptide and Production of a Fab from a HIV-1 Neutralizing Antibody for NMR Studies

By Sharon M.   Görlach M.   Levy R.   Hayek Y.   Anglister J.  

Protein Expression and Purification, Vol. 24, Iss. 3, 2002-04 ,pp. : 374-383

Academic Press

Access to resources Recommend Favorite